{"id":23410,"date":"2020-12-14T00:00:00","date_gmt":"2020-12-14T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/2020\/12\/14\/orientations-preliminaires-sur-les-principales-populations-a-immuniser-en-priorite-contre-la-covid-19\/"},"modified":"2020-12-14T00:00:00","modified_gmt":"2020-12-14T05:00:00","slug":"orientations-preliminaires-sur-les-principales-populations-a-immuniser-en-priorite-contre-la-covid-19","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2020\/12\/14\/orientations-preliminaires-sur-les-principales-populations-a-immuniser-en-priorite-contre-la-covid-19\/","title":{"rendered":"Orientations pr\u00e9liminaires sur les principales populations \u00e0 immuniser en priorit\u00e9 contre la COVID-19"},"content":{"rendered":"<p>Selon les orientations pr&eacute;liminaires du gouvernement du Canada sur les principales populations &agrave; immuniser en priorit&eacute; contre la COVID-19, les personnes atteintes de pathologies &agrave; haut risque sont class&eacute;es imm&eacute;diatement apr&egrave;s les travailleurs de la sant&eacute;. Vous trouverez l&rsquo;information &agrave; ce sujet <a href=\"https:\/\/www.canada.ca\/fr\/sante-publique\/services\/immunisation\/comite-consultatif-national-immunisation-ccni\/orientations-principales-populations-immuniser-priorite-covid-19.html.\" target=\"_blank\" rel=\"noopener\"><strong>ici<\/strong><\/a> :<\/p>\n<p>Les services de sant&eacute; publique des provinces et territoires sont responsables de la d&eacute;termination des priorit&eacute;s en mati&egrave;re de vaccination sur leur territoire.<\/p>\n<p>Il convient cependant de r&eacute;pondre &agrave; certaines questions importantes. Le vaccin sera-t-il efficace chez les patients atteints d&rsquo;un my&eacute;lome? Sera-t-il s&eacute;curitaire? Nous attendons donc avec impatience les conseils de la communaut&eacute; d&rsquo;experts canadiens et internationaux en mati&egrave;re de my&eacute;lome (c&#39;est-&agrave;-dire, le Canadian Myeloma Research Group et l&rsquo;International Myeloma Working Group).<\/p>\n<p>Nous pourrions trouver des liens vers tous les sites web des provinces et territoires, ou trouver un article qui en fait le r&eacute;sum&eacute;.<\/p>\n<p>Par exemple&nbsp;:<\/p>\n<ul>\n<li><strong>&nbsp;<a href=\"https:\/\/www.huffingtonpost.ca\/entry\/covid-vaccine-distribution-canada_ca_5fd0ce8fc5b66a7584111181\" target=\"_blank\" rel=\"noopener\">https:\/\/www.huffingtonpost.ca\/entry\/covid-vaccine-distribution-canada_ca_5fd0ce8fc5b66a7584111181<\/a> <\/strong>(mais cet article n&rsquo;est pas assez d&eacute;taill&eacute;).<\/li>\n<li>&nbsp;<strong><a href=\"https:\/\/www.ctvnews.ca\/health\/coronavirus\/what-provinces-and-territories-have-said-about-covid-19-vaccine-plans-1.5219892\" target=\"_blank\" rel=\"noopener\">https:\/\/www.ctvnews.ca\/health\/coronavirus\/what-provinces-and-territories-have-said-about-covid-19-vaccine-plans-1.5219892<\/a><\/strong><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Selon les orientations pr&eacute;liminaires du gouvernement du Canada sur les principales populations &agrave; immuniser en priorit&eacute; contre la COVID-19, les personnes atteintes de pathologies &agrave; haut risque sont class&eacute;es imm&eacute;diatement apr&egrave;s les travailleurs de la sant&eacute;. Vous trouverez l&rsquo;information &agrave; ce sujet ici : Les services de sant&eacute; publique des provinces et territoires sont responsables [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[72],"tags":[],"class_list":["post-23410","post","type-post","status-publish","format-standard","hentry","category-actualites-et-nouvelles-au-sujet-de-la-covid-19"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=23410"}],"version-history":[{"count":0,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23410\/revisions"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=23410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=23410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=23410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}